Version: 1.0.0 | Published: 7 Jan 2026 | Updated: 52 days ago
Documentation
Description:
PlasmaMATCH is a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening.
Clinical data and sample collection
Coverage
Spatial:
United Kingdom
Provenance
Temporal
Accrual Periodicity:
Static
Start Date:
10 September 2020
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
Please contact the publisher using Contact Point details provided
Access Request Cost:
Not specified
Delivery Lead Time:
Other
Jurisdictions:
UK
Data Controller:
The Institute of Cancer Research
Data Processor:
The Institute of Cancer Research
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Conforms To:
LOCAL
Languages:
en
Formats:
In Progress